Cargando…

Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma

BACKGROUND: Therapeutic management of Locally Advanced Rectal Cancer (LARC) involves pre-operative chemoradiotherapy (pCRT) followed by surgery. However, after pCRT the complete pathological response is approximately 20%, whereas in 20 to 40% of patients the response is poor or absent. METHODS: Canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	D'Angelo, Edoardo, Fassan, Matteo, Maretto, Isacco, Pucciarelli, Salvatore, Zanon, Carlo, Digito, Maura, Rugge, Massimo, Nitti, Donato, Agostini, Marco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053752/ https://www.ncbi.nlm.nih.gov/pubmed/27081702 http://dx.doi.org/10.18632/oncotarget.8725

Ejemplares similares

An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer
por: Agostini, Marco, et al.
Publicado: (2015)

Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression
por: Perilli, Lisa, et al.
Publicado: (2014)

Relationship between hospital volume and short-term outcomes: a nationwide population-based study including 75,280 rectal cancer surgical procedures
por: Pucciarelli, Salvatore, et al.
Publicado: (2018)

Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy
por: Spolverato, Gaya, et al.
Publicado: (2011)

Gene and protein expression of mTOR and LC3 in hepatocellular carcinoma, colorectal liver metastasis and “normal” liver tissues
por: Bortolami, Marina, et al.
Publicado: (2020)

Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases
por: Fassan, Matteo, et al.
Publicado: (2018)

Correction to: Assessment of intratumor immune-microenvironment in colorectal cancers with extranodal extension of nodal metastases
por: Fassan, Matteo, et al.
Publicado: (2019)

Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients
por: Dreussi, Eva, et al.
Publicado: (2016)

Recellularized Colorectal Cancer Patient-Derived Scaffolds as In Vitro Pre-Clinical 3D Model for Drug Screening
por: Sensi, Francesca, et al.
Publicado: (2020)

The Study of the Extracellular Matrix in Chronic Inflammation: A Way to Prevent Cancer Initiation?
por: Marangio, Asia, et al.
Publicado: (2022)

SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer
por: Terrin, Liliana, et al.
Publicado: (2017)

Tryptophan Metabolism as Source of New Prognostic Biomarkers for FAP Patients
por: Crotti, Sara, et al.
Publicado: (2019)

Intrinsic and Extrinsic Modulators of the Epithelial to Mesenchymal Transition: Driving the Fate of Tumor Microenvironment
por: D'Angelo, Edoardo, et al.
Publicado: (2020)

18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy
por: Capelli, Giulia, et al.
Publicado: (2022)

Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
por: Dreussi, Eva, et al.
Publicado: (2016)

Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer
por: Bertorelle, R, et al.
Publicado: (2013)

miR-224 Is Significantly Upregulated and Targets Caspase-3 and Caspase-7 During Colorectal Carcinogenesis()()
por: Fassan, Matteo, et al.
Publicado: (2018)

Obesity may not be related to pathologic response in locally advanced rectal cancer following neoadjuvant chemoradiotherapy
por: Bao, Quoc Riccardo, et al.
Publicado: (2022)

Tumor Cells and the Extracellular Matrix Dictate the Pro-Tumoral Profile of Macrophages in CRC
por: Coletta, Sara, et al.
Publicado: (2021)

Potential of miR-21 to Predict Incomplete Response to Chemoradiotherapy in Rectal Adenocarcinoma
por: Ourô, Susana, et al.
Publicado: (2020)

Long-Term Outcomes of Local Excision Following Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
por: D’Alimonte, Lucrezia, et al.
Publicado: (2020)

Tryptophan Catabolism and Response to Therapy in Locally Advanced Rectal Cancer (LARC) Patients
por: Crotti, Sara, et al.
Publicado: (2020)

Optimization of Biomimetic, Leukocyte-Mimicking Nanovesicles for Drug Delivery Against Colorectal Cancer Using a Design of Experiment Approach
por: Rampado, Riccardo, et al.
Publicado: (2022)

PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus
por: Fassan, Matteo, et al.
Publicado: (2019)

Utility of Restaging MRI Following Neoadjuvant Chemoradiotherapy for Stage II-III Rectal Adenocarcinoma
por: Aryan, Mahmoud, et al.
Publicado: (2021)

Immune surveillance activation after neoadjuvant therapy for esophageal adenocarcinoma and complete response
por: Kotsafti, Andromachi, et al.
Publicado: (2020)

Development of a long non-coding RNA signature for prediction of response to neoadjuvant chemoradiotherapy in locally advanced rectal adenocarcinoma
por: Ferrando, Lorenzo, et al.
Publicado: (2020)

Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases
por: Coati, Irene, et al.
Publicado: (2019)

Predictors of Metastatic Lymph Nodes at Preoperative Staging CT in Gastric Adenocarcinoma
por: Crimì, Filippo, et al.
Publicado: (2022)

Do pathological variables have prognostic significance in rectal adenocarcinoma treated with neoadjuvant chemoradiotherapy and surgery?
por: Reggiani Bonetti, Luca, et al.
Publicado: (2017)

Chemoradiotherapy response in recurrent rectal cancer
por: Yu, Stanley K T, et al.
Publicado: (2014)

Next-generation sequencing for genetic testing of familial colorectal cancer syndromes
por: Simbolo, Michele, et al.
Publicado: (2015)

Imaging for guiding a more tailored approach in rectal cancer patients
por: Spolverato, Gaya, et al.
Publicado: (2022)

Long non-coding RNA and extracellular matrix: the hidden players in cancer-stroma cross-talk
por: D'Angelo, Edoardo, et al.
Publicado: (2018)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
por: Molinari, Chiara, et al.
Publicado: (2011)

Effect of Neoadjuvant Chemoradiotherapy on Locally Advanced Rectal Mucinous Adenocarcinoma: A Propensity Score-Matched Study
por: Sun, Yan-wu, et al.
Publicado: (2017)

Assessment of clinical and pathological complete response after neoadjuvant chemoradiotherapy in rectal adenocarcinoma and its therapeutic implications
por: Alexandrescu, Sorin Tiberiu, et al.
Publicado: (2021)

Predicting Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Mucinous Adenocarcinoma Using an MRI-Based Radiomics Nomogram
por: Li, Zhihui, et al.
Publicado: (2021)

SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy
por: De Mattia, Elena, et al.
Publicado: (2021)

Neck emergency due to parathyroid adenoma bleeding: a case report
por: Merante-Boschin, Isabella, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_5d71q2ik1ps38rovhes1dlb3rs